Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One-year randomized double-masked study of bimatoprost 0.03% for eyelash hypotrichosis
2009-012304-55Phase 3Completed
- Sponsor
- Allergan
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in eyelash hypotrichosis and hypotrichosis comparing Bimatoprost 0.03% solution with Vehicle control (2 arms). Primary endpoint: Primary efficacy endpoint at month 4. Started May 2009; status: completed.
02
Drugs
bimatoprost
03
Conditions
eyelash hypotrichosishypotrichosis
Beyond the preview
Go deeper on 2009-012304-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012304-55.